drugset / Trial / NCT02511665
Metformin And Longevity
Phase 4
Unknown
185 enrolled
Guy's and St Thomas' NHS Foundation Trust
King's College London · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This is a randomized, placebo-controlled, double-blind, window of opportunity study investigating the biological mechanism of metformin in prostate cancer.
Timeline
- Start
- 2015-07
- Primary completion
- 2017-07
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1 g | — |